These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 20112070

  • 1. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B, Liu W, Wang L, Li M, Wang J, Huang L, Huang P, Yuan Y.
    Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
    [Abstract] [Full Text] [Related]

  • 2. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ, Wang L, Wang JP, Li JQ, Zhang CQ, Zheng L, Yuan YF.
    Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
    [Abstract] [Full Text] [Related]

  • 3. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C, Li Z, Cheng Y, Jia F, Li R, Wu M, Li K, Wei L.
    Clin Cancer Res; 2007 Feb 01; 13(3):944-52. PubMed ID: 17289889
    [Abstract] [Full Text] [Related]

  • 4. Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma.
    Cheng Y, Zhang C, Zhao J, Wang C, Xu Y, Han Z, Jiang G, Guo X, Li R, Bu X, Wu M, Wei L.
    Exp Mol Pathol; 2010 Feb 01; 88(1):112-7. PubMed ID: 19879258
    [Abstract] [Full Text] [Related]

  • 5. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 01; 30(11):831-6. PubMed ID: 19173828
    [Abstract] [Full Text] [Related]

  • 6. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M.
    Clin Cancer Res; 2006 May 15; 12(10):2995-3002. PubMed ID: 16707594
    [Abstract] [Full Text] [Related]

  • 7. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
    Ko E, Kim Y, Kim SJ, Joh JW, Song S, Park CK, Park J, Kim DH.
    Cancer Epidemiol Biomarkers Prev; 2008 Sep 15; 17(9):2260-7. PubMed ID: 18723830
    [Abstract] [Full Text] [Related]

  • 8. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, Nakayama H, Yasui W.
    Cancer; 2006 Mar 15; 106(6):1250-9. PubMed ID: 16475210
    [Abstract] [Full Text] [Related]

  • 9. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G.
    Hepatology; 2002 Aug 15; 36(2):427-32. PubMed ID: 12143052
    [Abstract] [Full Text] [Related]

  • 10. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.
    Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857
    [Abstract] [Full Text] [Related]

  • 11. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
    Liu Z, Zhao J, Chen XF, Li W, Liu R, Lei Z, Liu X, Peng X, Xu K, Chen J, Liu H, Zhou QH, Zhang HT.
    Lung Cancer; 2008 Oct 15; 62(1):15-22. PubMed ID: 18358560
    [Abstract] [Full Text] [Related]

  • 12. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.
    Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835
    [Abstract] [Full Text] [Related]

  • 13. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
    Roman-Gomez J, Jimenez-Velasco A, Agirre X, Prosper F, Heiniger A, Torres A.
    J Clin Oncol; 2005 Oct 01; 23(28):7043-9. PubMed ID: 16192589
    [Abstract] [Full Text] [Related]

  • 14. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
    Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, Hosokawa M, Shinomura Y, Imai K, Tokino T.
    Cancer; 2006 Apr 01; 106(7):1467-79. PubMed ID: 16518809
    [Abstract] [Full Text] [Related]

  • 15. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS.
    Ann Surg Oncol; 2008 Dec 01; 15(12):3494-502. PubMed ID: 18830757
    [Abstract] [Full Text] [Related]

  • 16. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.
    Ann Surg Oncol; 2010 Mar 01; 17(3):923-32. PubMed ID: 19898900
    [Abstract] [Full Text] [Related]

  • 17. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma.
    Zhang C, Guo X, Jiang G, Zhang L, Yang Y, Shen F, Wu M, Wei L.
    Int J Cancer; 2008 Sep 01; 123(5):998-1004. PubMed ID: 18546260
    [Abstract] [Full Text] [Related]

  • 18. Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation.
    Wu LM, Zhang F, Zhou L, Yang Z, Xie HY, Zheng SS.
    BMC Cancer; 2010 Aug 02; 10():399. PubMed ID: 20678188
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW, Ou YH, Peng SY, Liu SH, Lai PL, Lee PH, Sheu JC, Chen CL, Hsu HC.
    Cancer; 2003 Jul 01; 98(1):119-27. PubMed ID: 12833464
    [Abstract] [Full Text] [Related]

  • 20. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
    Pang JZ, Qin LX, Ren N, Hei ZY, Ye QH, Jia WD, Sun BS, Lin GL, Liu DY, Liu YK, Tang ZY.
    Clin Cancer Res; 2007 Dec 15; 13(24):7363-9. PubMed ID: 18094418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.